| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | K_chnl_volt-dep_Kv6 | 9.07e-06 | 3 | 33 | 2 | IPR003969 | |
| Domain | K_chnl_volt-dep_Kv | 1.03e-03 | 27 | 33 | 2 | IPR003968 | |
| Domain | VG_K_chnl | 1.54e-03 | 33 | 33 | 2 | IPR028325 | |
| Domain | BTB_2 | 3.94e-03 | 53 | 33 | 2 | PF02214 | |
| Domain | T1-type_BTB | 3.94e-03 | 53 | 33 | 2 | IPR003131 | |
| Domain | Channel_four-helix_dom | 4.55e-03 | 57 | 33 | 2 | IPR027359 | |
| Domain | - | 4.55e-03 | 57 | 33 | 2 | 1.20.120.350 | |
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 1.04e-06 | 2 | 36 | 2 | 5558567 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12034498 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22575451 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 3035575 | ||
| Pubmed | Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). | 1.04e-06 | 2 | 36 | 2 | 3498943 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 1534146 | ||
| Pubmed | Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. | 1.04e-06 | 2 | 36 | 2 | 8108731 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 1.04e-06 | 2 | 36 | 2 | 7889415 | |
| Pubmed | Murine Ly-3 restriction fragment length polymorphism and transcript size differences. | 1.04e-06 | 2 | 36 | 2 | 2576243 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 3025647 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2452747 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9233619 | ||
| Pubmed | Stalk region of beta-chain enhances the coreceptor function of CD8. | 1.04e-06 | 2 | 36 | 2 | 12847256 | |
| Pubmed | The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. | 1.04e-06 | 2 | 36 | 2 | 9647223 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 408079 | ||
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 1.04e-06 | 2 | 36 | 2 | 8436166 | |
| Pubmed | Characterization of the mouse CD8 beta chain-encoding gene promoter region. | 1.04e-06 | 2 | 36 | 2 | 8781121 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 3169881 | ||
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 1.04e-06 | 2 | 36 | 2 | 7103930 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19582788 | ||
| Pubmed | Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2 for Ly-3 surface expression. | 3.12e-06 | 3 | 36 | 2 | 3258885 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 3378837 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22081144 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 1541829 | ||
| Pubmed | Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus. | 3.12e-06 | 3 | 36 | 2 | 100557 | |
| Pubmed | Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. | 3.12e-06 | 3 | 36 | 2 | 9830036 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16356863 | ||
| Pubmed | Genetic correlation of a mouse light chain variable region marker with a thymocyte surface antigen. | 3.12e-06 | 3 | 36 | 2 | 4547628 | |
| Pubmed | Linkage of a 7S RNA sequence and kappa light chain genes in the mouse. | 3.12e-06 | 3 | 36 | 2 | 2998983 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 2493728 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9218488 | ||
| Pubmed | A new mouse lymphocyte alloantigen (Ly-35) controlled by the Ly-2/3 region on chromosome 6. | 3.12e-06 | 3 | 36 | 2 | 3346044 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23311920 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12810689 | ||
| Pubmed | A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice. | 3.12e-06 | 3 | 36 | 2 | 9126989 | |
| Pubmed | CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. | 3.12e-06 | 3 | 36 | 2 | 11754824 | |
| Pubmed | The synthesis and processing of beta-glucuronidase in normal and egasyn deficient mouse kidney. | 3.12e-06 | 3 | 36 | 2 | 7236294 | |
| Pubmed | Constitutive CD8 expression drives innate CD8+ T-cell differentiation via induction of iNKT2 cells. | 3.12e-06 | 3 | 36 | 2 | 31980555 | |
| Pubmed | An essential role for the stalk region of CD8 beta in the coreceptor function of CD8. | 3.12e-06 | 3 | 36 | 2 | 19109142 | |
| Pubmed | Endobrevin maps to chromosome 2 in human and chromosome 6 in mouse. | 3.12e-06 | 3 | 36 | 2 | 9878266 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19625641 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18929574 | ||
| Pubmed | Recombination between kappa chain genetic markers in the mouse. | 3.12e-06 | 3 | 36 | 2 | 6437974 | |
| Pubmed | Calyculin A inhibits expression of CD8alpha but not CD4 in human peripheral blood T cells. | 3.12e-06 | 3 | 36 | 2 | 11131152 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10795739 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 8064243 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24807710 | ||
| Pubmed | CD8beta knockout mice mount normal anti-viral CD8+ T cell responses--but why? | 3.12e-06 | 3 | 36 | 2 | 19088062 | |
| Pubmed | CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR. | 3.12e-06 | 3 | 36 | 2 | 17506031 | |
| Pubmed | Bop: a new T-cell-restricted gene located upstream of and opposite to mouse CD8b. | 3.12e-06 | 3 | 36 | 2 | 7590968 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11719190 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 2875941 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 14568922 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9013956 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9973530 | ||
| Pubmed | Differential susceptibility of mouse Lyt-2 and Lyt-3 genes to negative regulation. | 3.12e-06 | 3 | 36 | 2 | 8423051 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 2784466 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 7710778 | ||
| Pubmed | Mapping the binding site on CD8 beta for MHC class I reveals mutants with enhanced binding. | 3.12e-06 | 3 | 36 | 2 | 16951356 | |
| Pubmed | Recombination between kappa chain genetic markers and the Lyt-3 locus. | 3.12e-06 | 3 | 36 | 2 | 6411613 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15661911 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12459555 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 24695322 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18523287 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21115736 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16203967 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 24297179 | ||
| Pubmed | CD8 is needed for development of cytotoxic T cells but not helper T cells. | 6.24e-06 | 4 | 36 | 2 | 1673361 | |
| Pubmed | Ly antigens associated with T cell recognition and effector function. | 6.24e-06 | 4 | 36 | 2 | 6442265 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20535589 | ||
| Pubmed | T cell killing does not require the formation of a stable mature immunological synapse. | 6.24e-06 | 4 | 36 | 2 | 15048111 | |
| Pubmed | CD3 delta establishes a functional link between the T cell receptor and CD8. | 6.24e-06 | 4 | 36 | 2 | 12215456 | |
| Pubmed | Joint associations between genetic variants and reproductive factors in glioma risk among women. | 6.24e-06 | 4 | 36 | 2 | 21920947 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8537123 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10369133 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23575529 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9126927 | ||
| Pubmed | Ligand-engaged TCR is triggered by Lck not associated with CD8 coreceptor. | 1.04e-05 | 5 | 36 | 2 | 25427562 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 28341741 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 17082573 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 25548254 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 3138071 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 11403253 | ||
| Pubmed | Chromosomal localization of the genes encoding rat CD4, CD8alpha, and CD8beta. | 1.04e-05 | 5 | 36 | 2 | 8753864 | |
| Pubmed | Interaction between 5 genetic variants and allergy in glioma risk. | 1.56e-05 | 6 | 36 | 2 | 20462933 | |
| Pubmed | Sequence and evolution of the human T-cell antigen receptor beta-chain genes. | 1.56e-05 | 6 | 36 | 2 | 3860845 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 16491076 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 2898504 | ||
| Pubmed | An anchored molecular map of mouse chromosome 6 with an analysis of interference. | 1.56e-05 | 6 | 36 | 2 | 8563173 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 24069263 | ||
| Pubmed | Genetic risk profiles identify different molecular etiologies for glioma. | 1.56e-05 | 6 | 36 | 2 | 20847058 | |
| Pubmed | Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. | 2.18e-05 | 7 | 36 | 2 | 24610012 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 11956078 | ||
| Pubmed | Genetic nomenclature for loci controlling mouse lymphocyte antigens. | 2.18e-05 | 7 | 36 | 2 | 3817907 | |
| Pubmed | Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. | 2.18e-05 | 7 | 36 | 2 | 5021438 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 8100806 | ||
| Pubmed | Genome-wide association study identifies five susceptibility loci for glioma. | 2.91e-05 | 8 | 36 | 2 | 19578367 | |
| Pubmed | Initial characterization of STS markers in the LSXSS series of recombinant inbred strains. | 2.91e-05 | 8 | 36 | 2 | 8012109 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 10704459 | ||
| GeneFamily | Potassium voltage-gated channels | 9.76e-04 | 40 | 21 | 2 | 274 | |
| GeneFamily | PDZ domain containing | 1.33e-02 | 152 | 21 | 2 | 1220 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.51e-06 | 156 | 36 | 4 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.15e-06 | 164 | 36 | 4 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.37e-06 | 165 | 36 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.37e-06 | 165 | 36 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.01e-05 | 168 | 36 | 4 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-05 | 168 | 36 | 4 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 169 | 36 | 4 | 96aafb687b34d4b59f75c24e176b0b442e864245 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 170 | 36 | 4 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.32e-05 | 180 | 36 | 4 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.32e-05 | 180 | 36 | 4 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-05 | 180 | 36 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 181 | 36 | 4 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 141 | 36 | 3 | bb77b8d12e33dc82859abd79e56a574781f815dc | |
| ToppCell | VE-CD8-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.30e-04 | 148 | 36 | 3 | f49f579650b57cc4c6c7a7fa726447740d3dc695 | |
| ToppCell | MS-CD8-CD8_2|MS / Condition, Cell_class and T cell subcluster | 2.39e-04 | 150 | 36 | 3 | 01c20d787ce269db0d153e63a600a8d9ead61856 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.58e-04 | 154 | 36 | 3 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 2.68e-04 | 156 | 36 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 156 | 36 | 3 | 71f49db7d6da5533ecfcd4eacb50ecf1f30ee712 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-3|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.79e-04 | 158 | 36 | 3 | ec1a71b8f46179642b5af20e27764bb43c4b8e99 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 159 | 36 | 3 | a5509f0604ef0caef5ed1af83dd89c86686c73cc | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-04 | 159 | 36 | 3 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-04 | 159 | 36 | 3 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.84e-04 | 159 | 36 | 3 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-04 | 160 | 36 | 3 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.94e-04 | 161 | 36 | 3 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.94e-04 | 161 | 36 | 3 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | b83a35c4426d66b5734a98fa6c72b345fe462030 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.16e-04 | 165 | 36 | 3 | c042cde64b61ae195e1054f7b560151dabbfdf0d | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.16e-04 | 165 | 36 | 3 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 165 | 36 | 3 | 207f9ca8839f54710e2112986def4bc7b0ef1a28 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 3.22e-04 | 166 | 36 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-04 | 168 | 36 | 3 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 3.45e-04 | 170 | 36 | 3 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 170 | 36 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 3.51e-04 | 171 | 36 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 171 | 36 | 3 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 3.57e-04 | 172 | 36 | 3 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | IIH-CD8-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 3.57e-04 | 172 | 36 | 3 | 1466cb4298c63e995b3368d296b254e0e76a1b41 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 172 | 36 | 3 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 3.57e-04 | 172 | 36 | 3 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-04 | 175 | 36 | 3 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.88e-04 | 177 | 36 | 3 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.88e-04 | 177 | 36 | 3 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.01e-04 | 179 | 36 | 3 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.08e-04 | 180 | 36 | 3 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-04 | 180 | 36 | 3 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-04 | 181 | 36 | 3 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.15e-04 | 181 | 36 | 3 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.15e-04 | 181 | 36 | 3 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 4.21e-04 | 182 | 36 | 3 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 182 | 36 | 3 | 8b16a13d8606d21a7a9ce1175237e9b4cf832ee0 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-04 | 183 | 36 | 3 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-04 | 183 | 36 | 3 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.28e-04 | 183 | 36 | 3 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.35e-04 | 184 | 36 | 3 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 4.35e-04 | 184 | 36 | 3 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-04 | 185 | 36 | 3 | 3d6711030ca4328357b06d5497cf98cdefcd7f4f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-04 | 185 | 36 | 3 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.42e-04 | 185 | 36 | 3 | 99fe59c15c3c0f7afa7e182255e4bacfba346132 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.42e-04 | 185 | 36 | 3 | 191d7e9b34bd1598cb4c18e0cb3d018bad83c757 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 187 | 36 | 3 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.56e-04 | 187 | 36 | 3 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-04 | 189 | 36 | 3 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-04 | 191 | 36 | 3 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-04 | 191 | 36 | 3 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 191 | 36 | 3 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 191 | 36 | 3 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.08e-04 | 194 | 36 | 3 | a8dc3336aa4ef497f6d26cede02ddac425e7c655 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-04 | 195 | 36 | 3 | a7c70284ac47dcc6f47ee2805b76b14edfa1c0b9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.15e-04 | 195 | 36 | 3 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.15e-04 | 195 | 36 | 3 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.15e-04 | 195 | 36 | 3 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| Disease | neutrophil count | 3.16e-05 | 1382 | 36 | 9 | EFO_0004833 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 7.90e-05 | 11 | 36 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | Adrenal Cancer | 7.90e-05 | 11 | 36 | 2 | C0750887 | |
| Disease | Adrenal Gland Neoplasms | 7.90e-05 | 11 | 36 | 2 | C0001624 | |
| Disease | Malignant Glioma | 8.63e-05 | 70 | 36 | 3 | C0555198 | |
| Disease | mixed gliomas | 8.63e-05 | 70 | 36 | 3 | C0259783 | |
| Disease | B-cell acute lymphoblastic leukemia | 1.50e-04 | 15 | 36 | 2 | EFO_0000094 | |
| Disease | Back pain | 1.65e-04 | 87 | 36 | 3 | HP_0003418 | |
| Disease | Glioma | 1.65e-04 | 87 | 36 | 3 | C0017638 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 3.29e-04 | 22 | 36 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Lymphatic Metastasis | 4.62e-04 | 26 | 36 | 2 | C0024232 | |
| Disease | Micronuclei, Chromosome-Defective | 4.62e-04 | 26 | 36 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 4.62e-04 | 26 | 36 | 2 | C1449862 | |
| Disease | hippocampus volume change measurement, age at assessment | 5.76e-04 | 29 | 36 | 2 | EFO_0008007, EFO_0021492 | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 6.16e-04 | 30 | 36 | 2 | DOID:0050908 (is_implicated_in) | |
| Disease | Mesothelioma | 1.15e-03 | 41 | 36 | 2 | C0025500 | |
| Disease | high grade glioma (is_implicated_in) | 1.21e-03 | 42 | 36 | 2 | DOID:3070 (is_implicated_in) | |
| Disease | left ventricular systolic function measurement | 1.33e-03 | 44 | 36 | 2 | EFO_0008206 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.71e-03 | 50 | 36 | 2 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.85e-03 | 52 | 36 | 2 | C0023452 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 2.06e-03 | 55 | 36 | 2 | DOID:9952 (is_implicated_in) | |
| Disease | neutrophil count, eosinophil count | 2.22e-03 | 213 | 36 | 3 | EFO_0004833, EFO_0004842 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKIMRFLRRCRHSPL | 1641 | Q9Y6Y1 | |
| MFCRPRRQRLSHSRR | 6 | A0A3B3IU63 | |
| GCVLVLMARRRLARR | 301 | O96018 | |
| MVRRFLVTLRIRRAC | 1 | Q8N726 | |
| RTRQMRCRDYRLRLA | 326 | P48546 | |
| RSPYCKRMNRRRHAI | 341 | Q6PL18 | |
| MRRLRRLAHLVLFCP | 1 | Q5VUD6 | |
| LDSMRSILRNHRYRR | 656 | Q6IN85 | |
| HSAVMERLRRRIELC | 16 | Q92585 | |
| CKQRMLAREERHRRR | 216 | Q16206 | |
| RALRVLYVMRLARHS | 291 | Q9UJ96 | |
| FSVILNLIRMHRRSR | 216 | P43116 | |
| NLIRMHRRSRRSRCG | 221 | P43116 | |
| MRLHRLRARLSAVAC | 1 | O00748 | |
| LTALLLVAMICRRRR | 416 | Q50LG9 | |
| RALRILYVMRLARHS | 346 | Q9UIX4 | |
| RCALRSTRRFVMLRD | 96 | Q92985 | |
| RRAMKRNARLRCPFR | 66 | O75469 | |
| ARRCHMNRTLEFNRR | 181 | Q99575 | |
| RLLSRRLMFCVHARQ | 36 | Q8TAB7 | |
| RVRRMFRLSAALHLL | 6 | Q92896 | |
| MHLCCRRRRARLRFM | 191 | A6NJW9 | |
| IHLCCRRRRARLRFM | 191 | P10966 | |
| LSLLLFMVHRLRQRR | 361 | P98153 | |
| MARRRRRACIALFLV | 1 | Q5VSG8 | |
| CARRVAMLRIVHRRV | 936 | Q9Y613 | |
| VHILRRRIDRVMTCL | 551 | Q9P225 | |
| ARRGFCDARRRLMKR | 266 | O75900 | |
| HQLCCRMPRTLRRLF | 261 | Q96JT2 | |
| FFLLILSLRRHIRRM | 201 | Q9NYW3 | |
| RRMHRPRSCSYQLLL | 46 | O95398 | |
| RHRRAHMRRRLYICA | 276 | Q7L3S4 | |
| HLMPCDTLARRRLAR | 1311 | Q9P227 | |
| VLDCHRMRRRLPSQR | 386 | P18887 | |
| IRDACLRADRVMRAH | 221 | Q86XE0 | |
| LLRRFRHRARCLAMT | 86 | Q8WVP5 | |
| AMRLDRKIRLRHACA | 526 | P16473 |